アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/08/06 | 1,676 | 1,722 | 1,584 | 1,627 | -9.5 | -0.6% | 17,489,700 |
2024/08/05 | 1,684.5 | 1,722 | 1,621 | 1,636.5 | -108.5 | -6.2% | 15,812,000 |
2024/08/02 | 1,734.5 | 1,762.5 | 1,695.5 | 1,745 | +31 | +1.8% | 18,644,600 |
2024/08/01 | 1,736.5 | 1,736.5 | 1,698 | 1,714 | -33.5 | -1.9% | 7,111,300 |
2024/07/31 | 1,732 | 1,749 | 1,719 | 1,747.5 | +18 | +1% | 9,633,600 |
2024/07/30 | 1,720 | 1,730 | 1,710.5 | 1,729.5 | +19 | +1.1% | 7,916,900 |
2024/07/29 | 1,698.5 | 1,714.5 | 1,687 | 1,710.5 | +21.5 | +1.3% | 7,789,200 |
2024/07/26 | 1,678 | 1,697.5 | 1,666 | 1,689 | +25 | +1.5% | 6,282,900 |
2024/07/25 | 1,660 | 1,669.5 | 1,641.5 | 1,664 | +4 | +0.2% | 5,379,100 |
2024/07/24 | 1,650 | 1,672 | 1,644.5 | 1,660 | +6 | +0.4% | 4,592,100 |
2024/07/23 | 1,642 | 1,656.5 | 1,638.5 | 1,654 | +17.5 | +1.1% | 3,627,400 |
2024/07/22 | 1,644 | 1,648 | 1,620.5 | 1,636.5 | -5.5 | -0.3% | 3,501,400 |
2024/07/19 | 1,657 | 1,663 | 1,625 | 1,642 | -55 | -3.2% | 9,695,600 |
2024/07/18 | 1,687 | 1,704 | 1,678 | 1,697 | +9 | +0.5% | 6,558,100 |
2024/07/17 | 1,667 | 1,697.5 | 1,665.5 | 1,688 | +33 | +2% | 6,754,100 |
2024/07/16 | 1,656 | 1,660 | 1,644 | 1,655 | -2 | -0.1% | 4,617,800 |
2024/07/12 | 1,655 | 1,664.5 | 1,647.5 | 1,657 | -5 | -0.3% | 6,881,900 |
2024/07/11 | 1,645 | 1,665 | 1,642.5 | 1,662 | +32 | +2% | 7,450,300 |
2024/07/10 | 1,625 | 1,632 | 1,612 | 1,630 | +0.5 | ±0% | 6,399,000 |
2024/07/09 | 1,612 | 1,635 | 1,606.5 | 1,629.5 | +20 | +1.2% | 5,509,000 |
2024/07/08 | 1,625 | 1,632 | 1,603.5 | 1,609.5 | -7 | -0.4% | 8,737,900 |
2024/07/05 | 1,615 | 1,623 | 1,604.5 | 1,616.5 | +12.5 | +0.8% | 6,136,600 |
2024/07/04 | 1,592 | 1,605 | 1,584 | 1,604 | +14 | +0.9% | 4,112,200 |
2024/07/03 | 1,585 | 1,595 | 1,583 | 1,590 | +2 | +0.1% | 4,632,300 |
2024/07/02 | 1,584 | 1,592 | 1,569 | 1,588 | -0.5 | ±0% | 6,589,400 |
2024/07/01 | 1,590.5 | 1,593 | 1,567 | 1,588.5 | -1.5 | -0.1% | 6,761,000 |
2024/06/28 | 1,605 | 1,609 | 1,585 | 1,590 | -9 | -0.6% | 8,161,300 |
2024/06/27 | 1,578 | 1,614 | 1,566 | 1,599 | +15 | +0.9% | 13,702,400 |
2024/06/26 | 1,575.5 | 1,599 | 1,567 | 1,584 | +5.5 | +0.3% | 8,991,800 |
2024/06/25 | 1,564.5 | 1,588 | 1,557.5 | 1,578.5 | +16 | +1% | 5,825,900 |
2024/06/24 | 1,542 | 1,566.5 | 1,536.5 | 1,562.5 | +33 | +2.2% | 6,467,800 |
2024/06/21 | 1,495 | 1,538 | 1,494 | 1,529.5 | +32.5 | +2.2% | 9,711,900 |
2024/06/20 | 1,499 | 1,504 | 1,488 | 1,497 | -5.5 | -0.4% | 3,873,000 |
2024/06/19 | 1,500.5 | 1,508.5 | 1,493.5 | 1,502.5 | -2.5 | -0.2% | 4,073,500 |
2024/06/18 | 1,507 | 1,512 | 1,488 | 1,505 | -4.5 | -0.3% | 5,067,000 |
2024/06/17 | 1,506.5 | 1,513 | 1,495.5 | 1,509.5 | +7.5 | +0.5% | 4,709,900 |
2024/06/14 | 1,483 | 1,510 | 1,482 | 1,502 | -4.5 | -0.3% | 11,925,300 |
2024/06/13 | 1,556 | 1,556 | 1,502.5 | 1,506.5 | -60.5 | -3.9% | 8,194,700 |
2024/06/12 | 1,563 | 1,569 | 1,549 | 1,567 | -12 | -0.8% | 4,191,000 |
2024/06/11 | 1,590 | 1,596.5 | 1,574 | 1,579 | +2.5 | +0.2% | 5,214,100 |
2024/06/10 | 1,595.5 | 1,597 | 1,568 | 1,576.5 | -13.5 | -0.8% | 4,848,900 |
2024/06/07 | 1,583 | 1,600.5 | 1,579 | 1,590 | +3.5 | +0.2% | 5,106,700 |
2024/06/06 | 1,595 | 1,602.5 | 1,583 | 1,586.5 | -8 | -0.5% | 6,315,400 |
2024/06/05 | 1,566 | 1,599.5 | 1,565.5 | 1,594.5 | +17.5 | +1.1% | 7,577,200 |
2024/06/04 | 1,550 | 1,579.5 | 1,543 | 1,577 | +19.5 | +1.3% | 6,620,700 |
2024/06/03 | 1,562.5 | 1,570 | 1,545 | 1,557.5 | +9 | +0.6% | 5,259,600 |
2024/05/31 | 1,536.5 | 1,554 | 1,531 | 1,548.5 | +28.5 | +1.9% | 19,855,300 |
2024/05/30 | 1,524.5 | 1,528 | 1,501 | 1,520 | -15.5 | -1% | 7,142,200 |
2024/05/29 | 1,555 | 1,558 | 1,525.5 | 1,535.5 | -27 | -1.7% | 6,325,100 |
2024/05/28 | 1,564 | 1,570 | 1,551.5 | 1,562.5 | -7 | -0.4% | 4,676,000 |
251~
300
件表示中 / 3763件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 167,100円 | +0.9% | +380.2% | 4.67% | 23.02倍 | 1.98倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
第一三共 | 367,600円 | +6.0% | +4.0% | 2.12% | 22.68倍 | 4.19倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
大塚HD | 789,000円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 262,600円 | +20.9% | +10.6% | 2.51% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 263,300円 | -3.5% | -11.3% | 2.28% | 24.18倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム